Skip Navigation

Faculty Search Results

  New Search

Faculty List for Program: "Pharmacology"

Faculty Search Results: Results 1 - 20 (List more/fewer results: 10 20 30 40 )
Faculty Member Brief Research Description
Richard Auchus Steroid biosynthesis, enzymology, human diseases  
Asim Beg Molecular mechanisms underlying circuit assembly and synaptic function.  
Dean Brenner Translational pharmacology of nutritional cancer preventive interventions, pharmacokinetics, pharmacodynamics using stem cell, eicosanoid, and fatty acid endpoints in humans, rodents.  
Christine Canman Cancer Pharmacology and mechanisms promoting genome stability: We are investigating how specialized DNA polymerases are regulated by the Fanconi anemia pathway and influence the therapeutic response of cells treated with ionizing radiation or DNA crosslinking agents.   
Tom Carey I have two labs, one that is investigating the basis for autoimmune hearing loss and the other is investigating biomarkers in head and neck cancer that predict response to therapy and survival as well as identifying new targets for novel therapy.  
Eugene CHEN Dr. Chenís research program in cardiovascular medicine is elucidating the molecular basis of diabetes/obesity-induced cardiovascular diseases and stroke.   
Mark S. Cohen Development of novel drugs including naturally derived withanolides, novel HSP90 inhibitors and nanoparticle drug delivery systems for improved treatment of cancers, bone and wound healing, sepsis, and endocrine diseases.  
Carrie Ferrario We aim to understand the neural mechanisms underling drug addiction and obesity in order to develop prevention and treatment strategies.  
Margaret Gnegy Mechanism of action of amphetamine at the dopamine transporter; substrate and protein kinase effects on transporter trafficking; nicotine potentiation of amphetamine activity.  
Michael Holinstat development of novel therapeutics for prevention of platelet activation and thrombosis  
Paul Hollenberg Our laboratory studies human cytochrome P450s which play critical roles in drug and chemical carcinogen metabolism and toxicity.  
Jorge Iniguez-Lluhi - Protein Regulation by SUMO modification - Basic Mechanisms of Transcriptional Regulation - Mechanism of Action and Pathobiology of Steroid Hormone Receptors - Clinical Glucocorticoid Resistance - Multiscale Modeling   
Lori L. Isom Role of voltage-gated ion channels in normal development and in pathophysiology e.g. epilepsy, ataxia, arrhythmia, and Multiple Sclerosis. Cellular and molecular neuroscience. Cardiovascular biology. Molecular mechanisms of disease.  
Paul Jenkins We study the basic cellular and molecular mechanisms underlying complex neuropsychiatric diseases, such as bipolar disorder and schizophrenia.  
Emily Jutkiewicz Developmental and opioid-related mechanisms contributing to psychiatric diseases, such as depression and substance abuse  
Bob Kennedy We are studying hormone and neurotransmitter secretion with application to diabetes and various brain functions and pathophysiologies.  
Benedict (Ben) Lucchesi Cardiovascular pharmacology involving unique models that mimic diseases of the heart, blood and blood vessels and the development therapeutic interventions.  
Jon Maybaum Use of cell cycle checkpoint inhibitors to improve the therapeutic effectiveness of chemotherapy and radiation in cancer treatment   
Rick Mortensen 

The major goal of my laboratory has been to understand basic mechanisms in the pathophysiology, consequences and treatment of endocrine abnormalities particularly in obesity, diabetes and related cardiovascular and neurologic diseases. Recent focus has been on the function of drug targets that are clinically important nuclear receptors in immune modulation, and consequences in endocrine, neurologic and cardiovascular diseases. This has also been broadened to other ways of modulating immune function.  
1 2